Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
In this supplement we added new stability information to the monographs for ACYCLOVIR SODIUM, CEFIDEROCOL SULFATE TOSYLATE, FLUOROURACIL, GANCICLOVIR SODIUM, INSULIN, REGULAR, MEROPENEM, PEMETREXED, and PHLOROGLUCINOL DIHYDRATE.
New compatibility information was added to the existing drug monographs for AMOXICILLIN SODIUM, AMPHOTERICIN B LIPOSOME, BUPIVACAINE HYDROCHLORIDE, CEFAZOLIN SODIUM, CEFEPIME HYDROCHLORIDE, CO-TRIMOXAZOLE, DAPTOMYCIN, DILTIAZEM HYDROCHLORIDE, HEPARIN SODIUM, INSULIN, REGULAR, KETOROLAC TROMETHAMINE, LEVETIRACETAM, LEVOFLOXACIN, MAGNESIUM SULFATE, PANTOPRAZOLE SODIUM, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, VORICONAZOLE, and POSACONAZOLE with 19 other drugs.